Adolor And GlaxoSmithKline Announce FDA Approval Of Entereg(R) (alvimopan) For The Management Of...

medicalnewstoday.com     May 22, 2008            

Adolor Corporation (Nasdaq:ADLR) and GlaxoSmithKline (NYSE:GSK) announced that the U.S. Food and Drug Administration has approved Entereg® (alvimopan) capsules to help patients regain gastrointestinal (GI) function earlier following bowel resection surgery. [read full story]                

Add a comment to the article
Type the code shown

View all news articles about:

- Related Topics